Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war? - sprookjes - yvandenbroek - TriplyDB

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

http://www.wikidata.org/entity/Q35270150

about

Adaptive immunity in the liver Natural killer cells in hepatitis C: Current progress Virological Mechanisms in the Coinfection between HIV and HCV A Systems Biology Approach to the Coordination of Defensive and Offensive Molecular Mechanisms in the Innate and Adaptive Host-Pathogen Interaction Networks.A systematic review and meta-analysis of HCV clearance.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.

P2860

Q26753195-E306BFAD-1DAD-4D15-A037-B64CEB433121 Q26773264-D3B6A06A-0DC8-469A-91C7-8E6CE285D9CA Q26780313-21205A32-1155-4744-98B0-785AB8ABC1D9 Q35924938-ACE775EE-11BB-4294-8F17-36CA13E8D25F Q38928083-F21295F6-40BC-4544-9985-29EF97A76C21 Q38945754-CB479675-DD76-4054-AEF0-3E6D6DC111DD Q40065913-3E907A03-C899-49C6-818C-F7C22F7AEE0B Q41928800-AF1C073C-1165-440E-95D2-8BCBCFDF86B0 Q42369135-26C4F39A-3BCA-4CC0-8287-A9BFF53A955E

P2860

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

http://www.wikidata.org/entity/Q35270150

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@ast

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@en

type

label

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@ast

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@en

prefLabel

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@ast

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@en

P1433

Q35270150-98BD4920-5F42-4E15-BAF6-CC4F9CBB9C11

P1476

Q35270150-843BA1EC-0B1C-4E0A-A172-6B36F662B169

P2093

Q35270150-7F4A6B4F-B352-4605-B86B-F0F30B8A7C4B

Q35270150-D15C1896-B7B3-4144-8B36-B6C5FCA5D00F

P2860

Q35270150-02C7B197-4EC2-41C9-93C8-B1D006DE7C83

Q35270150-04A76BC1-E38B-4DBA-883D-D103A6BC91BA

Q35270150-04DBFA85-32F2-409C-8401-DBE602D5D919

Q35270150-05848F4D-DB7C-42E8-AC32-CB8527E5FDF6

Q35270150-059D1103-6C56-4BEC-9D63-E0BF3E8EE9EC

Q35270150-0729889D-332A-4F74-B10E-C74398198E02

Q35270150-08B114D0-6BB8-4774-A222-BFD591DD1AE3

Q35270150-0B09BFE5-7797-4050-B51A-E486BF8D9896

Q35270150-0B430AB5-C37B-4F84-98AA-79E2D0237F43

Q35270150-0C9E08C3-02BB-4017-AC8A-53629B212FF2

P304

Q35270150-73CC38B2-CCE3-4B93-9F64-05C6675A9ABD

P31

Q35270150-F550592E-BC6F-4950-9F67-252A0FB07021

P356

Q35270150-41F99C5C-C454-40FF-876B-39AEAFBDE7E4

P407

Q35270150-56189D5C-8894-467C-AD7B-BB63EBB73A9D

P433

Q35270150-66C8AF98-3756-40A4-947A-46916ED81E15

P478

Q35270150-11395A67-53D4-4376-9643-DFD61365588D

P577

Q35270150-BBA2F58F-748C-4437-B9DB-A298B9B04175

P698

Q35270150-7007EF2B-F8FA-4E4A-8F14-6DD03A4450E7

P932

Q35270150-7EF92AC6-4DB4-45E4-AA43-3DD885C71303

P356

WJG.V21.I13.3786

P1433

World Journal of Gastroenterology

P1476

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

@en

P2093

Da-Rong Yang

http://www.w3.org/2001/XMLSchema#string

Hai-Zhen Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Peroxisomes are signaling platforms for antiviral innate immunity

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

P304

3786-3800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I13.3786

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25852264

http://www.w3.org/2001/XMLSchema#string

P932

4385526

http://www.w3.org/2001/XMLSchema#string